BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29066531)

  • 1. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
    Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
    Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
    Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
    Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Analysis Identifies Tenascin-C Expression Is Upregulated in Uterine Fibroids.
    Jamaluddin MFB; Nagendra PB; Nahar P; Oldmeadow C; Tanwar PS
    Reprod Sci; 2019 Apr; 26(4):476-486. PubMed ID: 29730954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of Somatic Mutation in MED12 Induces Wnt4/β-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell.
    El Andaloussi A; Al-Hendy A; Ismail N; Boyer TG; Halder SK
    Reprod Sci; 2020 Mar; 27(3):823-832. PubMed ID: 32046450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guizhi Fuling Capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/β-Catenin signaling pathway.
    Chen L; Chen H; Yang Q; Jiang Y; Liu L; Yu H; Chen Y; Li J; Chen N; Wang H; Wang Q
    J Ethnopharmacol; 2022 May; 290():115115. PubMed ID: 35181487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/β-Catenin Signaling Pathway.
    Al-Hendy A; Laknaur A; Diamond MP; Ismail N; Boyer TG; Halder SK
    Endocrinology; 2017 Mar; 158(3):592-603. PubMed ID: 27967206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.
    Jamaluddin MFB; Ko YA; Kumar M; Brown Y; Bajwa P; Nagendra PB; Skerrett-Byrne DA; Hondermarck H; Baker MA; Dun MD; Scott RJ; Nahar P; Tanwar PS
    Endocrinology; 2018 Feb; 159(2):1106-1118. PubMed ID: 29244110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells.
    Al-Hendy A; Diamond MP; Boyer TG; Halder SK
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1542-51. PubMed ID: 26820714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
    Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
    J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
    Markowski DN; Bartnitzke S; Löning T; Drieschner N; Helmke BM; Bullerdiek J
    Int J Cancer; 2012 Oct; 131(7):1528-36. PubMed ID: 22223266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MED12 alterations in both human benign and malignant uterine soft tissue tumors.
    Pérot G; Croce S; Ribeiro A; Lagarde P; Velasco V; Neuville A; Coindre JM; Stoeckle E; Floquet A; MacGrogan G; Chibon F
    PLoS One; 2012; 7(6):e40015. PubMed ID: 22768200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
    Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
    Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
    Corachán A; Ferrero H; Aguilar A; Garcia N; Monleon J; Faus A; Cervelló I; Pellicer A
    Fertil Steril; 2019 Feb; 111(2):397-407. PubMed ID: 30458994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
    Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A
    Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
    Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
    Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 activates Wnt/β-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate.
    Ali M; Stone D; Laknaur A; Yang Q; Al-Hendy A
    F S Sci; 2023 Aug; 4(3):239-256. PubMed ID: 37182601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Characterization of the Extracellular Matrix of Human Uterine Fibroids.
    Jamaluddin MFB; Nahar P; Tanwar PS
    Endocrinology; 2018 Jul; 159(7):2656-2669. PubMed ID: 29788081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
    Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
    Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
    de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
    Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.